HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2-tert-butyl-4-hydroxyanisole

Also Known As:

2-BHA

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Phenyl Ethers: 8
        Anisoles
        Butylated Hydroxyanisole: 515
        2-tert-butyl-4-hydroxyanisole: 2
- Ethers: 242
  - Methyl Ethers: 19
    - Anisoles
      - Butylated Hydroxyanisole: 515
        2-tert-butyl-4-hydroxyanisole: 2
  - Phenyl Ethers: 8
    - Anisoles
      - Butylated Hydroxyanisole: 515
        2-tert-butyl-4-hydroxyanisole: 2

Experts

1.	Fujisawa, Seiichiro: 2 articles (07/2006 - 05/2006)
2.	Murakami, Yukio: 2 articles (07/2006 - 05/2006)
3.	Shoji, Masao: 2 articles (07/2006 - 05/2006)
4.	Tanaka, Shoji: 2 articles (07/2006 - 05/2006)
5.	Yokoe, Ichiro: 2 articles (07/2006 - 05/2006)
6.	Ogiwara, Takako: 1 article (07/2006)
7.	Hanazawa, Shigemasa: 1 article (05/2006)
8.	Hirata, Atsushi: 1 article (05/2006)

Related Diseases

1.	Periodontal Diseases (Periodontal Disease) 05/15/2006 - "In the present study, toward our goal of developing a chemopreventive agent for chronic periodontal diseases, we examined whether 2-BHA (2-tert-butyl-4-methoxyphenol) and its synthetic ortho dimer, bis-BHA (3,3'-di-tert-butyl-5,5'-dimethoxy-1,1'-biphenyl-2,2'-diol) could inhibit the Porphyromonas gingivalis fimbria-stimulated inflammatory reaction. "
2.	Chronic Periodontitis 07/01/2006 - "To develop anti-inflammatory and/or anticancer drugs for the prevention of oral diseases, such as leukoplakia and destructive chronic periodontitis, whether 2-BHA (2-tert-butyl-4-methoxyphenol) and its synthetic ortho dimer, bis-BHA (3,3'-di-tert-butyl-5,5'-dimethoxy-1,1'-biphenyl-2,2'-diol) can inhibit AP-1 transcriptional activity stimulated by Porphyromonas gingivalis fimbriae was examined. "
3.	Leukoplakia 07/01/2006 - "To develop anti-inflammatory and/or anticancer drugs for the prevention of oral diseases, such as leukoplakia and destructive chronic periodontitis, whether 2-BHA (2-tert-butyl-4-methoxyphenol) and its synthetic ortho dimer, bis-BHA (3,3'-di-tert-butyl-5,5'-dimethoxy-1,1'-biphenyl-2,2'-diol) can inhibit AP-1 transcriptional activity stimulated by Porphyromonas gingivalis fimbriae was examined. "

Related Drugs and Biologics

1.	Butylated Hydroxyanisole (BHA)
2.	Transcription Factor AP-1 (Transcription Factor AP 1)